InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 ZLD Engages ICCI for Clinical Trial and Regulatory Expertise 12 Feb 2019 8:25AM $0.058 $0.500 risen by 762.07%
$7 Change of Director's Interest Notice 5 Feb 2019 4:13PM $0.055 $0.500 risen by 809.09%
$7 Appendix 4C - quarterly 30 Jan 2019 6:32PM $0.052 $0.500 risen by 861.54%
$7 December 2018 Quarterly Report and Board Transition 30 Jan 2019 6:32PM $0.052 $0.500 risen by 861.54%
$7 Notice of General Meeting 18 Jan 2019 6:22PM $0.057 $0.500 risen by 777.19%
$7 Appendix 3B 16 Jan 2019 6:16PM $0.059 $0.500 risen by 747.46%
$7 Response to ASX Appendix 3Y Query 16 Jan 2019 9:57AM $0.061 $0.500 risen by 719.67%
$7 Change in substantial holding 14 Jan 2019 5:09PM $0.061 $0.500 risen by 719.67%
$7 Change of Director's Interest Notice 14 Jan 2019 5:07PM $0.061 $0.500 risen by 719.67%
$7 Response to ASX Price and Volume Query 8 Jan 2019 7:09PM $0.066 $0.500 risen by 657.58%
$7 Change of Director's Interest Notice 14 Dec 2018 1:04PM $0.039 $0.500 risen by 1,182.05%
$7 Change of Director's Interest Notice 7 Dec 2018 5:16PM $0.050 $0.500 risen by 900%
$7 ZLD to Invest in Development of Oral Spray Formulations 6 Dec 2018 8:53AM $0.046 $0.500 risen by 986.96%
$7 SUD: SUDA Enters Agreement To Develop Cannabinoid Spray 6 Dec 2018 8:24AM $0.046 $0.500 risen by 986.96%
$7 Results of Meeting 30 Nov 2018 1:02PM $0.051 $0.500 risen by 880.39%
$7 Annual General Meeting Presentation 2018 30 Nov 2018 11:31AM $0.053 $0.500 risen by 843.40%
$7 Investor Presentation - Non-deal Roadshow 27 Nov 2018 8:21AM $0.047 $0.500 risen by 963.83%
$7 Opioid reduction clinical trial with St Vincent's Hospital 26 Nov 2018 8:22AM $0.046 $0.500 risen by 986.96%
$7 Appendix 3B 22 Nov 2018 6:22PM $0.046 $0.500 risen by 986.96%
$7 Correction to Unlisted Option Expiry Date 14 Nov 2018 6:29PM $0.055 $0.500 risen by 809.09%
$7 Release From Escrow and Founders Commitment Not to Sell 7 Nov 2018 8:24AM $0.064 $0.500 risen by 681.25%
$7 Appendix 4C - quarterly 31 Oct 2018 10:43AM $0.062 $0.500 risen by 706.45%
$7 September 2018 Quarterly Report 31 Oct 2018 10:42AM $0.062 $0.500 risen by 706.45%
$7 Notice of Annual General Meeting 29 Oct 2018 5:35PM $0.059 $0.500 risen by 747.46%
$7 Managing Director Remuneration Variation 12 Oct 2018 8:27AM $0.065 $0.500 risen by 669.23%

401 - 425 of 546 results

Page 17 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.